﻿<?xml version="1.0" encoding="utf-8"?><rss version="2.0"><channel><title>Clinical and Developmental Immunology</title><link>http://www.hindawi.com</link><description>The latest articles from Hindawi Publishing Corporation</description><copyright>&amp;#169; 2008, Hindawi Publishing Corporation. All rights reserved.</copyright><item><title>Neonatal and Infantile Immune Responses to Encapsulated Bacteria and Conjugate Vaccines</title><link>http://www.hindawi.com/GetArticle.aspx?doi=10.1155/2008/628963</link><description>Encapsulated bacteria are responsible for the majority of mortality among neonates and infants. The major components on the surface of these bacteria are polysaccharides which are important virulence factors. Immunity against these components protects against disease. However, most of the polysaccharides are thymus-independent (TI)-2 antigens which induce an inadequate immune response in neonates and infants. The mechanisms that are thought to play a role in the unresponsiveness of this age group to TI-2 stimuli will be discussed. The lack of immune response may be overcome by conjugating the polysaccharides to a carrier protein. This transforms bacterial polysaccharides from a TI-2 antigen into a thymus-dependent (TD) antigen, thereby inducing an immune response and immunological memory in neonates and infants. Such conjugated vaccines have been shown to be effective against the most common causes of invasive disease caused by encapsulated bacteria in neonates and children. These and several other approaches in current vaccine development will be discussed.</description><Author>Peter Klein Klouwenberg and Louis Bont</Author><copyright>&amp;#169; 2008, Hindawi Publishing Corporation. All rights reserved.</copyright></item><item><title>Comparative Study of Regulatory T Cell Function of Human CD25+CD4+ T Cells from Thymocytes, Cord Blood, and Adult Peripheral Blood</title><link>http://www.hindawi.com/GetArticle.aspx?doi=10.1155/2008/305859</link><description>CD25+CD4+ regulatory T cells suppress T cell activation and regulate multiple immune reactions in in vitro and in vivo studies. To define the regulatory function of human CD25+CD4+ T cells at various stages of maturity, we investigated in detail the functional differences of CD25+CD4+ T cells from thymocytes, cord blood (CB), and adult peripheral blood (APB). CB CD25+CD4+ T cells displayed low-FOXP3 protein expression level and had no suppressive activity. In contrast, CD25+CD4+ T cells from thymocytes or APB expressed high expression level of FOXP3 protein associated with significant suppressive activity. Although CB CD25+CD4+ T cells exhibited no suppressive activity, striking suppressive activity was observed following expansion in culture associated with increased FOXP3 expression and a shift from the CD45RA+ to the CD45RA&amp;#x2212; phenotype. These functional differences in CD25+CD4+ T cells from Thy, CB, and APB hence suggest a pathway of maturation for 
  Treg in the peripheral immune system.</description><Author>Wakae Fujimaki, Nozomu Takahashi, Kei Ohnuma, Masayoshi Nagatsu, Hiromi Kurosawa, Satoko Yoshida, Nam H. Dang, Takehiko Uchiyama, and Chikao Morimoto</Author><copyright>&amp;#169; 2008, Hindawi Publishing Corporation. All rights reserved.</copyright></item><item><title>Viral Infection: A Potent Barrier to Transplantation Tolerance</title><link>http://www.hindawi.com/GetArticle.aspx?doi=10.1155/2008/742810</link><description>Transplantation of allogeneic organs has proven to be an effective therapeutic for a large variety of disease states, but the chronic immunosuppression that is required for organ allograft survival increases the risk for infection and neoplasia and has direct organ toxicity. The establishment of transplantation tolerance, which obviates the need for chronic immunosuppression, is the ultimate goal in the field of transplantation. Many experimental approaches have been developed in animal models that permit long-term allograft survival in the absence of chronic immunosuppression. These approaches function by inducing peripheral or central tolerance to the allograft. Emerging as some of the most promising approaches for the induction of tolerance are protocols based on costimulation blockade. However, as these protocols move into the clinic, there is recognition that little is known as to their safety and efficacy when confronted with environmental perturbants such as virus infection. In animal models, it has been reported that virus infection can prevent the induction of tolerance by costimulation blockade and, in at least one experimental protocol, can lead to significant morbidity and mortality. In this review, we discuss how viruses modulate the induction and maintenance of transplantation tolerance.</description><Author>David M. Miller, Thomas B. Thornley, Dale L. Greiner, and Aldo A. Rossini</Author><copyright>&amp;#169; 2008, Hindawi Publishing Corporation. All rights reserved.</copyright></item><item><title>Aflatoxin-Related Immune Dysfunction in Health and in Human Immunodeficiency Virus Disease</title><link>http://www.hindawi.com/GetArticle.aspx?doi=10.1155/2008/790309</link><description>Both aflatoxin and the human immunodeficiency virus (HIV) cause immune suppression and millions of HIV-infected people in developing countries are chronically exposed to aflatoxin in their diets. We investigated the possible interaction of aflatoxin and HIV on immune suppression by comparing immune parameters in 116 HIV positive and 80 aged-matched HIV negative Ghanaians with high (&amp;#x2265;0.91&amp;#x2009;pmol/mg albumin) and low (&amp;#x003C;0.91&amp;#x2009;pmol/mg albumin) aflatoxin B1 albumin adduct (AF-ALB) levels. AF-ALB levels and HIV viral load were measured in plasma and the percentages of leukocyte immunophenotypes and cytokine expression were determined using flow cytometry. The cross-sectional comparisons found that (1) among both HIV positive and negative participants, high AF-ALB was associated with lower perforin expression on CD8+ T-cells (P=.012); (2) HIV positive participants with high AF-ALB had significantly lower percentages of CD4+ T regulatory cells (Tregs; P=.009) and naive CD4+ T cells (P=.029) compared to HIV positive participants with low AF-ALB; and (3) HIV positive participants with high AF-ALB had a significantly reduced percentage of B-cells (P=.03) compared to those with low AF-ALB. High AF-ALB appeared to accentuate some HIV associated changes in T-cell phenotypes and in B-cells in HIV positive participants.</description><Author>Yi Jiang, Pauline E. Jolly, Peter Preko, Jia-Sheng Wang, William O. Ellis, Timothy D. Phillips, and Jonathan H. Williams</Author><copyright>&amp;#169; 2008, Hindawi Publishing Corporation. All rights reserved.</copyright></item><item><title>Legume Lectin FRIL Preserves Neural Progenitor Cells in Suspension Culture In Vitro</title><link>http://www.hindawi.com/GetArticle.aspx?doi=10.1155/2008/531317</link><description>In vitro maintenance of stem cells is crucial for many clinical applications. Stem cell preservation factor FRIL (Flt3 receptor-interacting lectin) is a plant lectin extracted from Dolichos Lablab and has been found preserve hematopoietic stem cells in vitro for a month in our previous studies. To investigate whether FRIL can preserve neural progenitor cells (NPCs), it was supplemented into serum-free suspension culture media. FRIL made NPC grow slowly, induced cell adhesion, and delayed neurospheres formation. However, FRIL did not initiate NPC differentiation according to immunofluorescence and semiquantitive RT-PCR results. In conclusion, FRIL could also preserve neural progenitor cells in vitro by inhibiting both cell proliferation and differentiation.</description><Author>Hailei Yao, Xiaoyan Xie, Yanhua Li, Dongmei Wang, Shu Han, Shuangshuang Shi, Xue Nan, Cixian Bai, Yunfang Wang, and Xuetao Pei</Author><copyright>&amp;#169; 2008, Hindawi Publishing Corporation. All rights reserved.</copyright></item><item><title>A Possible Link between Infection with Burkholderia Bacteria and Systemic Lupus Erythematosus Based on Epitope Mimicry</title><link>http://www.hindawi.com/GetArticle.aspx?doi=10.1155/2008/683489</link><description>We previously demonstrated that purified polyclonal and monoclonal anti-dsDNA antibodies bind a 15-mer peptide ASPVTARVLWKASHV in ELISA and Dot blot. This 15-mer peptide partial sequence ARVLWKASH shares similarity with burkholderia bacterial cytochrome B 561 partial sequence ARVLWRATH. In this study, we show that purified anti-dsDNA antibodies react with burkholderia fungorum bacterial cell lysates in Western blot. We used anti-dsDNA antibodies to make an anti-dsDNA antibodies affinity column and used this column to purify the burkholderia fungorum bacterial protein. Purified anti-dsDNA antibodies bind specifically to purified bacterial antigen and purified bacterial antigen blocked the anti-dsDNA antibodies binding to dsDNA antigen. Sera with anti-dsDNA antibodies bind specifically to purified bacterial antigen. We obtained protein partial sequence of RAGTDEGFG which is shared with burkholderia bacterial transcription regulator protein sequence. Sera with anti-dsDNA antibodies bind to RAGTDEGFG peptide better than control groups. These data support our hypothesis that the origin of anti-dsDNA antibodies in SLE may be associated with burkholderia bacterial infection.</description><Author>Wei Zhang and Morris Reichlin</Author><copyright>&amp;#169; 2008, Hindawi Publishing Corporation. All rights reserved.</copyright></item><item><title>Lack of Disease Specificity Limits the Usefulness of In Vitro Costimulation in HIV- and HCV-Infected Patients</title><link>http://www.hindawi.com/GetArticle.aspx?doi=10.1155/2008/590941</link><description>Measurements of antigen-specific T cell responses in chronic diseases are limited by low frequencies of antigen-specific cells in the peripheral blood.  Therefore, attempts have been made to add costimulatory molecules such as anti-CD28 or IL-7/IL-15 to ELISPOT assays to increase sensitivity.  While this approach has been successful under certain circumstances, results are often inconsistent.  To date, there are no comprehensive studies directly comparing the in vitro effects of multiple costimulatory molecules in different disease settings.  Therefore, in the present study we tested the effects of IL-7/IL-15, IFN-&amp;#x03B1;, anti-ICOS, and anti-CD28 on antigen-specific T cell responses in patients infected with HCV or HIV versus healthy individuals. Our data show that none of the aforementioned molecules could significantly increase ELISPOT sensitivity, neither in HCV nor in HIV.  Moreover, all of them caused false-positive responses to HCV and HIV antigens in healthy individuals. Our results question the broad use of in vitro costimulation.</description><Author>Stefanie Kuerten, Tobias R. Schlingmann, Tarvo Rajasalu, Doychin N. Angelov, Paul V. Lehmann, and Magdalena Tary-Lehmann</Author><copyright>&amp;#169; 2008, Hindawi Publishing Corporation. All rights reserved.</copyright></item><item><title>Do the Changes in the Serum Levels of IL-2, IL-4, TNF&amp;#x03B1;, and IL-6 Reflect the Inflammatory Activity in the Patients with Post-ERCP Pancreatitis?</title><link>http://www.hindawi.com/GetArticle.aspx?doi=10.1155/2008/481560</link><description>Background. Acute pancreatitis is the major complication of endoscopic retrograde cholangiopancreatography (ERCP) procedure and there are some reports showing cytokine changes in ERCP-induced pancreatits.Goals. To investigate the association between early changes (within 24 hours) in the serum interleukin (IL)-2, IL-4, tumor necrosis factor (TNF)&amp;#x03B1;, and IL-6 levels and the development of post-ERCP pancreatitis. Study. Forty five consecutive patients who underwent therapeutic ERCP and 10 patients with acute pancreatitis without ERCP were enrolled to the study. Serum concentrations of IL-2, IL-4, TNF&amp;#x03B1;, and IL-6 were determined immediately before, 12 hours and 24 hours after ERCP. Results. Seven of the 45 patients (15.5&amp;#37;) developed post-ERCP pancreatitis. The levels of IL-4 at 24 hours after ERCP were significantly lower in the patients with post-ERCP pancreatitis than in those without pancreatitis, while TNF&amp;#x03B1; levels at 12 hours after ERCP were higher in the complicated group than those of the uncomplicated group. The ratios of TNF&amp;#x03B1;/IL-4 at 12 and 24 hours after ERCP were found significantly higher in the patients with post-ERCP pancreatitis than in those without pancreatitis. IL-6 in the complicated patients was found significantly increased at 24 hours after ERCP. Conclusions. The enhancement of serum TNF&amp;#x03B1; and IL-6 levels in the patients with ERCP-induced pancreatitis reflects the inflammatory activity. Additionally, these cytokines together with IL-4 can be used in clinical laboratory monitoring of ERCP.</description><Author>Guldem Kilciler, Ugur Musabak, Sait Bagci, Zeki Yesilova, Ahmet Tuzun, Ahmet Uygun, Mustafa Gulsen, Sema Oren, Cagatay Oktenli, and Necmettin Karaeren</Author><copyright>&amp;#169; 2008, Hindawi Publishing Corporation. All rights reserved.</copyright></item><item><title>The Fetal Allograft Revisited: Does the Study of an Ancient Invertebrate Species Shed Light on the Role of Natural Killer Cells at the Maternal-Fetal Interface?</title><link>http://www.hindawi.com/GetArticle.aspx?doi=10.1155/2008/631920</link><description>Human pregnancy poses a fundamental immunological problem because the placenta and fetus are genetically different from the host mother. Classical transplantation theory has not provided a plausible solution to this problem. Study of naturally occurring allogeneic chimeras in the colonial marine invertebrate, Botryllus schlosseri, has yielded fresh insight into the primitive development of allorecognition, especially regarding the role of natural killer (NK) cells. Uterine NK cells have a unique phenotype that appears to parallel aspects of the NK-like cells in the allorecognition system of B. schlosseri.  Most notably, both cell types recognize and reject &amp;#8220;missing self&amp;#8221; and both are involved in the generation of a common vascular system between two individuals. Chimeric combination in B. schlosseri results in vascular fusion between two individual colonies; uterine NK cells appear essential to the establishment of adequate maternal-fetal circulation. Since human uterine NK cells appear to de-emphasize primary immunological function, it is proposed that they may share the same evolutionary roots as the B. schlosseri allorecognition system rather than a primary origin in immunity.</description><Author>Amy Lightner, Danny J. Schust, Yi-Bin A. Chen, and Breton F. Barrier</Author><copyright>&amp;#169; 2008, Hindawi Publishing Corporation. All rights reserved.</copyright></item><item><title>Rituximab Administration in Third Trimester of Pregnancy Suppresses Neonatal B-Cell Development</title><link>http://www.hindawi.com/GetArticle.aspx?doi=10.1155/2008/271363</link><description>We describe the effect on the neonate of administration of rituximab to a woman with idiopathic thrombocytopenic purpura (ITP). Rituximab, an anti-CD20 antibody, was given weekly for 4 weeks to a woman with ITP in her third trimester of pregnancy. One month after the last rituximab administration a healthy girl was born. She had normal growth and development during the first six months. At birth, B-lymphocytes were not detectable. Rituximab levels in mother and neonate were 24000 and 6700&amp;#x2009;ng/mL, respectively. Only 7 cases of rituximab administration during pregnancy were described. No adverse events are described for fetus and neonate. We demonstrate that rituximab passes the placenta and inhibits neonatal B-lymphocyte development. However, after 6 months B-lymphocyte levels normalized and vaccination titres after 10 months were adequate. No infection-related complications occurred. Rituximab administration during pregnancy appears to be safe for the child but further studies are warranted.</description><Author>D. T. Klink, R. M. van Elburg, M. W. J. Schreurs, and G. T. J. van Well</Author><copyright>&amp;#169; 2008, Hindawi Publishing Corporation. All rights reserved.</copyright></item><item><title>Antigen-Induced Immunomodulation in the Pathogenesis of Atherosclerosis</title><link>http://www.hindawi.com/GetArticle.aspx?doi=10.1155/2008/723539</link><description>Atherosclerosis is a chronic inflammatory disorder characterised by the accumulation of monocytes/macrophages, smooth muscle cells, and lymphocytes within the arterial wall in response to the release of proinflammatory molecules. Such accumulation results in the formation of the atherosclerotic plaque, which would eventually evolve to complications such as total artery occlusion, rupture, calcification, or aneurysm. Although the molecular mechanism responsible for the development of atherosclerosis is not completely understood, it is clear that the immune system plays a key role in the development of the atherosclerotic plaque and in its complications. There are multiple antigenic stimuli that have been associated with the pathogenesis of atherosclerosis. Most of these stimuli come from modified self-molecules such as oxidised low-density lipoproteins (oxLDLs), beta2glycoprotein1 (&amp;#x3B2;2GP1), lipoprotein a (LP(a)), heat shock proteins (HSPs), and protein components of the extracellular matrix such as collagen and fibrinogen in the form of advanced glycation-end (AGE) products. In addition, several foreign antigens including bacteria such as Porphyromonas gingivalis and Chlamydia pneumoniae and viruses such as enterovirus and cytomegalovirus have been associated with atherosclerosis as potentially causative or bystander participants, adding another level of complexity to the analysis of the pathophysiology of atherosclerosis. The present review summarises the most important scientific findings published within the last two decades on the importance of antigens, antigen stimulation, and adaptive immune responses in the development of atherosclerotic plaques.</description><Author>Natalia Milioti, Alexandra Bermudez-Fajardo, Manuel L. Penichet, and Ernesto Oviedo-Orta</Author><copyright>&amp;#169; 2008, Hindawi Publishing Corporation. All rights reserved.</copyright></item><item><title>Worms and the Treatment of Inflammatory Bowel Disease: Are Molecules the Answer?</title><link>http://www.hindawi.com/GetArticle.aspx?doi=10.1155/2008/567314</link><description>The lack of exposure to helminth infections, as a result of improved living 
                  standards and medical conditions, may have contributed to the increased incidence of 
                  IBD in the developed world. Epidemiological, experimental, and clinical data sustain the 
                  idea that helminths could provide protection against IBD. Studies investigating the underlying 
                  mechanisms by which helminths might induce such protection have revealed the importance 
                  of regulatory pathways, for example, regulatory T-cells. Further investigation on how helminths 
                  influence both innate and adaptive immune reactions will shed more light on the complex 
                  pathways used by helminths to regulate the hosts immune system. Although therapy with 
                  living helminths appears to be effective in several immunological diseases, the disadvantages 
                  of a treatment based on living parasites are explicit. Therefore, the identification and 
                  characterization of helminth-derived immunomodulatory molecules that contribute to the 
                  protective effect could lead to new therapeutic approaches in IBD and other immune diseases.</description><Author>Nathalie E. Ruyssers, Benedicte Y. De Winter, Joris G. De Man, Alex Loukas, Arnold G. Herman, Paul A. Pelckmans, and Tom G. Moreels</Author><copyright>&amp;#169; 2008, Hindawi Publishing Corporation. All rights reserved.</copyright></item><item><title>Serial Assessment of Immune Status by Circulating CD8+ Effector T Cell Frequencies for Posttransplant Infectious Complications</title><link>http://www.hindawi.com/GetArticle.aspx?doi=10.1155/2008/718386</link><description>To clarify the role of CD8+ effector T cells for infectious complications, 92 recipients were classified according to the hierarchical clustering of preoperative CD8+CD45 isoforms: Group I was naive, Group II was effector memory, and Group III was effector (E) T cell-dominant. The posttransplant infection rates progressively increased from 29&amp;#37; in Group I to 64.3&amp;#37; in Group III recipients. The posttransplant immune status was compared with the pretransplant status, based on the measure (&amp;#37; difference) and its graphical form (scatter plot). In Groups I and II, both approaches showed a strong upward deviation from pretransplant status upon posttransplant infection, indicating an enhanced clearance of pathogens. In Group III, in contrast, both approaches showed a clear downward deviation from preoperative status, indicating deficient cytotoxicity. The &amp;#37; E difference and scatter plot can be used as a useful indicator of a posttransplant infectious complication.</description><Author>Shinji Uemoto, Kazue Ozawa, Hiroto Egawa, Yasutsugu Takada, Hiroshi Sato, Satoshi Teramukai, Mureo Kasahara, Kohei Ogawa, Masako Ono, Kenji Takai, Masanori Fukushima, Kayo Inaba, and Koichi Tanaka</Author><copyright>&amp;#169; 2008, Hindawi Publishing Corporation. All rights reserved.</copyright></item><item><title>Brucella abortus Strain RB51 Vaccine: Immune Response after Calfhood Vaccination  and   Field Investigation in Italian Cattle Population</title><link>http://www.hindawi.com/GetArticle.aspx?doi=10.1155/2008/584624</link><description>Immune response to Brucella abortus strain RB51 vaccine was measured in cattle vaccinated at calfhood. After an increase at day 6 post-vaccination (pv), the antibody level recorded in the 10 vaccinated animals remained constant for two months, and then progressively decreased. All vaccinated animals remained negative from day 162&amp;#x2009;pv to the end of the study (day 300&amp;#x2009;pv). Only at days 13 and 14&amp;#x2009;pv the RB51-CFT showed 100&amp;#37; sensitivity (credibility interval (CI) 76.2&amp;#37;&amp;#8211;100&amp;#37;). The results indicate that the possibility to use RB51-CFT for the identification of cattle vaccinated at calfhood with RB51 is limited in time. A field investigation was carried out on 26,975 sera collected on regional basis from the Italian cattle population. The study outcomes indicate that in case of RB51-CFT positive results observed in officially Brucellosis-free (OBF) areas and, in any case, when an illegal use of RB51 vaccine is suspected, the use of the RB51-CFT alone is not sufficient to identify all the vaccinated animals. The design of a more sophisticated diagnostic protocol including an epidemiological investigation, the use of RB51-CFT, and the use of the skin test with RB51 as antigen is deemed more appropriate for the identification of RB51 vaccinated  animals.</description><Author>Manuela Tittarelli, Barbara Bonfini, Fabrizio De Massis, Armando Giovannini, Mauro Di Ventura, Donatella Nannini, and Vincenzo Caporale</Author><copyright>&amp;#169; 2008, Hindawi Publishing Corporation. All rights reserved.</copyright></item><item><title>Regulation of FoxP3+ Regulatory T Cells and Th17 Cells by Retinoids</title><link>http://www.hindawi.com/GetArticle.aspx?doi=10.1155/2008/416910</link><description>Vitamin A has both positive and negative regulatory functions in the immune system. While vitamin A is required for normal formation of immune cells and epithelial cell barriers, vitamin A deficiency can lead to increased inflammatory responses and tissue damage. The mechanism with which vitamin A and its metabolites such as retinoids negatively regulate inflammatory responses has not been clearly defined. Recently, it has been established that retinoids promote the generation of immune-suppressive FoxP3+ regulatory T cells while they suppress the T cell differentiation into inflammatory Th17 cells in the periphery such as intestine. These novel functions of retinoids provide a potentially important immune regulatory mechanism. In this review, we discuss the functions of retinoids in the development of the FoxP3+ cells and Th17 cells, the phenotype and functions of retinoid-induced FoxP3+ T cells, and the impact of retinoid-induced FoxP3+ T cells on the immune tolerance.</description><Author>Chang H. Kim</Author><copyright>&amp;#169; 2008, Hindawi Publishing Corporation. All rights reserved.</copyright></item><item><title>Use of Recombinant Antigens for the Diagnosis of Invasive Candidiasis</title><link>http://www.hindawi.com/GetArticle.aspx?doi=10.1155/2008/721950</link><description>Invasive candidiasis is a frequent and often fatal complication in immunocompromised and critically ill patients. Unfortunately, the diagnosis of invasive candidiasis remains difficult due to the lack of specific clinical symptoms and a definitive diagnostic method. The detection of antibodies against different Candida  antigens may help in the diagnosis. However, the methods traditionally used for the detection of antibodies have been based on crude antigenic fungal extracts, which usually show low-reproducibility and cross-reactivity problems. The development of molecular biology techniques has allowed the production of recombinant antigens which may help to solve these problems. In this review we will discuss the usefulness of recombinant antigens in the diagnosis of invasive candidiasis.</description><Author>Ana La&amp;#237;n, Natalia Elguezabal, Elena Amutio, I&amp;#241;igo Fern&amp;#225;ndez de Larrinoa, Mar&amp;#237;a Dolores Moragues, and Jos&amp;#233; Pont&amp;#243;n</Author><copyright>&amp;#169; 2008, Hindawi Publishing Corporation. All rights reserved.</copyright></item><item><title>Methotrexate and Cyclosporine Treatments Modify the Activities of Dipeptidyl Peptidase IV and Prolyl Oligopeptidase in Murine Macrophages</title><link>http://www.hindawi.com/GetArticle.aspx?doi=10.1155/2008/794050</link><description>Analysis of the effects of cyclosporine A (25&amp;#x2013;28&amp;#x2009;mgkg&amp;#x2212;1) and/or methotrexate (0.1&amp;#x2009;mgkg&amp;#x2212;1) treatments on dipeptidyl peptidase IV (DPPIV) and prolyl oligopeptidase (POP) activities and on algesic response in two distinct status of murine macrophages (M&amp;#x03C6;s) was undertaken. In resident M&amp;#x03C6;s, DPPIV and POP were affected by neither individual nor combined treatments. In thioglycolate-elicited M&amp;#x03C6;s, methotrexate increased DPPIV (99&amp;#x2013;110&amp;#x25;) and POP (60&amp;#x25;), while cyclosporine inhibited POP (21&amp;#x25;). Combined treatment with both drugs promoted a rise (51&amp;#x2013;84&amp;#x25;) of both enzyme activities. Only cyclosporine decreased (42&amp;#x25;) the tolerance to algesic stimulus. Methotrexate was revealed to exert prevalent action over that of cyclosporine on proinflammatory M&amp;#x03C6; POP. The opposite effects of methotrexate and cyclosporine on POP activity might influence the availability of the nociceptive mediators bradykinin and substance P in proinflammatory M&amp;#x03C6;s. The exacerbated response to thermally induced algesia observed in cyclosporine-treated animals could be related to upregulation of those mediators.</description><Author>R. A. Olivo, N. G. Nascimento, C. F. P. Teixeira, and P. F. Silveira</Author><copyright>&amp;#169; 2008, Hindawi Publishing Corporation. All rights reserved.</copyright></item><item><title>Feeding Our Immune System: Impact on Metabolism</title><link>http://www.hindawi.com/GetArticle.aspx?doi=10.1155/2008/639803</link><description>Endogenous intestinal microflora and environmental factors, such as diet, play a central role in immune homeostasis and reactivity. In addition, microflora and diet both influence body weight and insulin-resistance, notably through an action on adipose cells. Moreover, it is known since a long time that any disturbance in metabolism, like obesity, is associated with immune alteration, for example, inflammation. The purpose of this review is to provide an update on how nutrients-derived factors (mostly focusing on fatty acids and glucose) impact the innate and acquired immune systems, including the gut immune system and its associated bacterial flora. We will try to show the reader how the highly energy-demanding immune cells use glucose as a main source of fuel in a way similar to that of insulin-responsive adipose tissue and how Toll-like receptors (TLRs) of the innate immune system, which are found on immune cells, intestinal cells, and adipocytes, are presently viewed as essential actors in the complex balance ensuring bodily immune and metabolic health. Understanding more about these links will surely help to study and understand in a more fundamental way the common observation that eating healthy will keep you and your immune system healthy.</description><Author>Isabelle Wolowczuk, Claudie Verwaerde, Odile Viltart, Anne Delanoye, Myriam Delacre, Bruno Pot, and Corinne Grangette</Author><copyright>&amp;#169; 2008, Hindawi Publishing Corporation. All rights reserved.</copyright></item><item><title>Human Brain Microvascular Endothelial Cells and Umbilical Vein Endothelial Cells Differentially Facilitate Leukocyte Recruitment and Utilize Chemokines for T Cell Migration</title><link>http://www.hindawi.com/GetArticle.aspx?doi=10.1155/2008/384982</link><description>Endothelial cells that functionally express blood brain barrier (BBB) properties are useful surrogates for studying leukocyte-endothelial cell interactions at the BBB. In this study, we compared two different endothelial cellular models: transfected human brain microvascular endothelial cells (THBMECs) and human umbilical vein endothelial cells (HUVECs). With each grow under optimal conditions, confluent THBMEC cultures showed continuous occludin and ZO-1 immunoreactivity, while HUVEC cultures exhibited punctate ZO-1 expression at sites of cell-cell contact only. Confluent THBMEC cultures on 24-well collagen-coated transwell inserts had significantly higher transendothelial electrical resistance (TEER) and lower solute permeability than HUVECs. Confluent THBMECs  were more restrictive for mononuclear cell migration than HUVECs. Only THBMECs utilized abluminal CCL5 to facilitate T-lymphocyte migration in vitro although both THBMECs and HUVECs employed CCL3 to facilitate T cell migration. These data establish baseline conditions for using THBMECs to develop in vitro BBB models for studying leukocyte-endothelial interactions during neuroinflammation.</description><Author>Shumei Man, Eroboghene E. Ubogu, Katherine A. Williams, Barbara Tucky, Melissa K. Callahan, and Richard M. Ransohoff</Author><copyright>&amp;#169; 2008, Hindawi Publishing Corporation. All rights reserved.</copyright></item><item><title>Pro- and Anti-Inflammatory Cytokine Balance in Major Depression: Effect of Sertraline Therapy</title><link>http://www.hindawi.com/GetArticle.aspx?doi=10.1155/2007/76396</link><description>The specific associations between antidepressant treatment and alterations in the levels of cytokines remain to be elucidated. In this study, we aimed to explore the role of IL-2, IL-4, IL-12, TNF-&amp;#x03B1;, TGF-&amp;#x03B2;1, and MCP-1 in major depression and to investigate the effects of sertraline therapy. Cytokine and chemokine levels were measured at the time of admission and 8 weeks after sertraline treatment. Our results suggest that the proinflammatory cytokines (IL-2, IL-12, and TNF-&amp;#x03B1;) and MCP-1 were significantly higher, whereas anti-inflammatory cytokines IL-4 and TGF-&amp;#x03B2;1 were significantly lower in patients with major depression than those of healthy controls. It seems likely that the sertraline therapy might have exerted immunomodulatory effects through a decrease in the proinflammatory cytokine IL-12 and an increase in the anti-inflammatory cytokines IL-4 and TGF-&amp;#x03B2;1. In conclusion, our results indicate that Th1-, Th2-, and Th3-type cytokines are altered in the depressed patients and some of them might have been corrected by sertraline treatment.</description><Author>Levent Sutcigil, Cagatay Oktenli, Ugur Musabak, Ali Bozkurt, Adnan Cansever, Ozcan Uzun, S. Yavuz Sanisoglu, Zeki Yesilova, Nahit Ozmenler, Aytekin Ozsahin, and Ali Sengul</Author><copyright>&amp;#169; 2008, Hindawi Publishing Corporation. All rights reserved.</copyright></item><item><title>Regulatory T Cells and Human Disease</title><link>http://www.hindawi.com/GetArticle.aspx?doi=10.1155/2007/89195</link><description>The main function of our immune system is to protect us from invading pathogens and microorganisms by
destroying infected cells, while minimizing collateral damage to tissues.  In order to maintain this balance between
immunity and tolerance, current understanding of the immune system attributes a major role to regulatory T cells
(Tregs) in controlling both immunity and tolerance. Various subsets of Tregs have been identified based on their
expression of cell surface markers, production of cytokines, and mechanisms of action. In brief, naturally occurring
thymic-derived CD4+CD25+ Tregs are characterized by constitutive expression of the transcription factor FOXP3, while
antigen-induced or adaptive Tregs are mainly identified by expression of immunosuppressive cytokines
(interleukin-10 (IL-10) and/or transforming growth factor-&amp;#x03B2; (TGF-&amp;#x03B2;)). While Tregs in normal conditions regulate
ongoing immune responses and prevent autoimmunity, imbalanced function or number of these Tregs, either
enhanced or decreased, might lead, respectively, to decreased immunity (e.g., with tumor development or infections)
or autoimmunity (e.g., multiple sclerosis). This review will discuss recent research towards a better understanding of the
biology of Tregs, their interaction with other immune effector cells, such as dendritic cells, and possible interventions in
human disease.</description><Author>Nathalie Cools, Peter Ponsaerts, Viggo F. I. Van Tendeloo, and Zwi N. Berneman</Author><copyright>&amp;#169; 2008, Hindawi Publishing Corporation. All rights reserved.</copyright></item><item><title>Defective Differentiation of Myeloid and Plasmacytoid Dendritic Cells in Advanced Cancer Patients is not Normalized by Tyrosine Kinase Inhibition of the Vascular Endothelial Growth Factor Receptor</title><link>http://www.hindawi.com/GetArticle.aspx?doi=10.1155/2007/17315</link><description>Tumor-derived vascular endothelial growth factor (VEGF) has previously been identified as a causative factor in the disturbed differentiation of myeloid dendritic cells (DC) in advanced cancer patients. Here, we investigated the potential of vascular endothelial growth factor receptor (VEGFR) tyrosine kinase (TK) inhibition to overcome this defective DC differentiation. To this end, peripheral blood DC (PBDC) precursor and subset frequencies were measured in 13 patients with advanced cancer before and after treatment with AZD2171, a TK inhibitor (TKI) of VEGFR, coadministered with gefitinib, and an epidermal growth factor receptor (EGFR) TKI. Of note, not only myeloid DC but also plasmacytoid DC frequencies were significantly reduced in the blood of the cancer patients prior to treatment, as compared to healthy controls. Moreover, besides an accumulated population of immature myeloid cells (ImC), a population of myeloid suppressor cells (MSC) was significantly increased. Upon systemic VEGFR TK inhibition, DC frequencies did not increase, whereas the rate of circulating MSC showed a slight, but not significant, decrease. In conclusion, TK inhibition of VEGFR with AZD2171 does not restore the defective PBDC differentiation observed in advanced cancer patients.</description><Author>H. van Cruijsen, K. Hoekman, A. G. M. Stam, A. J. M. van den Eertwegh, B. C. Kuenen, R. J. Scheper, G. Giaccone, and T. D. de Gruijl</Author><copyright>&amp;#169; 2008, Hindawi Publishing Corporation. All rights reserved.</copyright></item><item><title>Attenuated Disease in SIV-Infected Macaques Treated with 
      a Monoclonal Antibody against FasL</title><link>http://www.hindawi.com/GetArticle.aspx?doi=10.1155/2007/93462</link><description>Acute SIVmac infection in macaques is accompanied by high levels of plasma viremia that decline with the appearance of viral immunity and is a model for acute HIV disease in man. Despite specific immune responses, the virus establishes a chronic, persistent infection. The destruction of CD4+ 
 and CD4- lymphocyte subsets in macaques 
contributes to viral persistence and suggests the 
importance of mechanisms for depleting both infected 
and uninfected (bystander) cells. Bystander cell killing 
can occur when FasL binds the Fas receptor on activated lymphocytes, 
which include T and B cell subpopulations that are responding to the 
infection. Destruction of specific immune cells could be an important 
mechanism for blunting viral immunity and establishing persistent infection 
with chronic disease. We inhibited the Fas pathway in vivo with a monoclonal 
antibody against FasL (RNOK203). Here we show that treatment with anti-FasL 
reduced cell death in circulating T and B cells, increased CTL and antibody 
responses to viral proteins, and lowered the setpoint viremia. By blocking 
FasL during only the first few weeks after infection, we attenuated SIVmac 
disease and increased the life span for infected and treated macaques.</description><Author>Maria S. Salvato, C. Cameron Yin, Hideo Yagita, Toshihiro Maeda, Ko Okumura, Ilia Tikhonov, and C. David Pauza</Author><copyright>&amp;#169; 2008, Hindawi Publishing Corporation. All rights reserved.</copyright></item><item><title>Blurring Borders: Innate Immunity with Adaptive Features</title><link>http://www.hindawi.com/GetArticle.aspx?doi=10.1155/2007/83671</link><description>Adaptive immunity has often been considered the 
penultimate of immune capacities. That system is now being 
deconstructed to encompass less stringent rules that govern its 
initiation, actual effector activity, and ambivalent results. 
Expanding the repertoire of innate immunity found in all 
invertebrates has greatly facilitated the relaxation of 
convictions concerning what actually constitutes innate and 
adaptive immunity. Two animal models, incidentally not on the line 
of chordate evolution (C. elegans and 
Drosophila), have contributed enormously to defining 
homology. The characteristics of specificity and 
memory and whether the antigen is pathogenic or nonpathogenic 
reveal considerable information on homology, thus 
deconstructing the more fundamentalist view. Senescence, cancer, 
and immunosuppression often associated with mammals that possess 
both innate and adaptive immunity also exist in invertebrates 
that only possess innate immunity. Strict definitions become 
blurred casting skepticism on the utility of creating rigid 
definitions of what innate and adaptive immunity are without 
considering overlaps.</description><Author>K. Kvell, EL. Cooper, P. Engelmann, J. Bovari, and P. Nemeth</Author><copyright>&amp;#169; 2008, Hindawi Publishing Corporation. All rights reserved.</copyright></item><item><title>Angioedema: Clinical and Etiological Aspects</title><link>http://www.hindawi.com/GetArticle.aspx?doi=10.1155/2007/26438</link><description>Angioedema is an abrupt swelling of the skin, mucous membrane, or both including respiratory and gastrointestinal tracts. This study aimed to report an experience of angioedema in a university hospital with respect to etiologies, clinical features, treatment, and outcome. One hundred and five patients were enrolled. About half had angioedema without urticaria. The common sites of involvement were periorbital area and lips. Forty five patients (49&amp;#37;) had systemic symptoms. The most common cause of angioedema was allergic angioedema. Nonsteroidal anti-inflammatory drug-induced angioedema and idiopathic angioedema were detected in 20&amp;#37; and 18&amp;#37;, respectively. Among patients with allergic angioedema, 41.7&amp;#37; were caused by food, 39.6&amp;#37; by drugs. Thirty seven patients (39&amp;#37;) had recurrent attacks of angioedema. Mean standard deviation (SD) number of attacks in patients with recurrent angioedema was 3.9 (2.7) (ranging from 2 to 10 times). Patients who had older age and multiple sites of skin involvement had tendency to have systemic symptoms.</description><Author>Kanokvalai Kulthanan, Sukhum Jiamton, Kanonrat Boochangkool, and Kowit Jongjarearnprasert</Author><copyright>&amp;#169; 2008, Hindawi Publishing Corporation. All rights reserved.</copyright></item><item><title>The Possible Correlation between the Patient&amp;#39;s Immune Tolerance Level During Cesaerean Section and the Incidence of Subsequent Emergency Peripartum Hysterectomy</title><link>http://www.hindawi.com/GetArticle.aspx?doi=10.1155/2007/63596</link><description>Introduction. Cesarean section is an independent risk factor for peripartum hysterectomy. As a method of delivery, cesarean section may interfere with a number of molecular changes that occur at the maternal-fetal interface during the course of labor. Methods. The level of CD3, CD56, CD25, and CD69 antigen immunoreactivity was assessed by immunohistochemistry in 26 decidual tissue samples. The tissue samples were obtained from 18 women who underwent cesarean sections at term and from 8 women who underwent cesarean hysterectomies. Results. An increase in the activity and infiltration of immune cells in the decidua sampled during the spontaneous beginning of labor was observed.  The further progression of labor was accompanied by a decrease in the number and activity of immune cells.  The number of CD56+ and CD3+ 
 cells in the decidua was statistically significantly lower in patients who had undergone cesarean hysterectomies than in those who had had cesarean sections at term. Conclusion. Abnormal immune response during labor may increase the risk for peripartum hysterectomy.</description><Author>Lukasz Wicherek and Krystna Galazka</Author><copyright>&amp;#169; 2008, Hindawi Publishing Corporation. All rights reserved.</copyright></item><item><title>The Immune Response Is Involved in Atherosclerotic Plaque Calcification: Could the RANKL/RANK/OPG System Be a Marker of Plaque Instability?</title><link>http://www.hindawi.com/GetArticle.aspx?doi=10.1155/2007/75805</link><description>Atherogenesis is characterized by an intense inflammatory process, involving immune and vascular cells. These cells play a crucial role in all phases of atherosclerotic plaque formation and complication through cytokine, protease, and prothrombotic factor secretion. The accumulation of inflammatory cells and thus high amounts of soluble mediators are responsible for the evolution of some plaques to instable phenotype which may lead to rupture. One condition strongly associated with plaque rupture is calcification, a physiopathological process orchestrated by several soluble factors, including the receptor activator of nuclear factor NF&amp;#x03BA;B ligand (RANKL)/receptor activator of nuclear factor NF&amp;#x03BA;B (RANK)/osteoprotegerin (OPG) system. Although some studies showed some interesting correlations with acute ischemic events, at present, more evidences are needed to evaluate the predictive and diagnostic value of serum sRANKL and OPG levels for clinical use. The major limitation is probably the poor specificity of these factors for cardiovascular disease. The identification of tissue-specific isoforms could increase the importance of sRANKL and OPG in predicting calcified plaque rupture and the dramatic ischemic consequences in the brain and the heart.</description><Author>Fabrizio Montecucco, Sabine Steffens, and Fran&amp;#231;ois Mach</Author><copyright>&amp;#169; 2008, Hindawi Publishing Corporation. All rights reserved.</copyright></item><item><title>Soluble Triggering Receptor Expressed on Myeloid Cells 1 Is Released in Patients with Stable Chronic Obstructive Pulmonary Disease</title><link>http://www.hindawi.com/GetArticle.aspx?doi=10.1155/2007/52040</link><description>Chronic obstructive pulmonary disease (COPD) is increasingly recognized as a systemic disease that is associated with increased serum levels of markers of systemic inflammation. The triggering receptor expressed on myeloid cells 1 (TREM-1) is a recently identified activating receptor on neutrophils, monocytes, and macrophage subsets. TREM-1 expression is upregulated by microbial products such as the toll-like receptor ligand lipoteichoic acid of Gram-positive or lipopolysaccharides of Gram-negative bacteria. In the present study, sera from 12 COPD patients (GOLD stages I&amp;#8211;IV, FEV1 51 &amp;#x00B1; 6&amp;#37;) and 10 healthy individuals were retrospectively analyzed for soluble TREM-1 (sTREM-1) using a newly developed ELISA. In healthy subjects, sTREM-1 levels were low (median 0.25 ng/mL, range 0&amp;#8211;5.9 ng/mL). In contrast, levels of sTREM-1 in sera of COPD patients were significantly increased (median 11.68 ng/mL, range 6.2&amp;#8211;41.9 ng/mL, P&amp;#x003C;.05). Furthermore, serum levels of sTREM-1 showed a significant negative correlation with lung function impairment. In summary, serum concentrations of sTREM-1 are increased in patients with COPD. Prospective studies are warranted to evaluate the relevance of sTREM-1 as a potential marker of the disease in patients with COPD.</description><Author>Markus P. Radsak, Christian Taube, Philipp Haselmayer, Stefan Tenzer, Helmut R. Salih, Rainer Wiewrodt, Roland Buhl, and Hansj&amp;#246;rg Schild</Author><copyright>&amp;#169; 2008, Hindawi Publishing Corporation. All rights reserved.</copyright></item><item><title>CRALBP is a Highly Prevalent Autoantigen for Human Autoimmune Uveitis</title><link>http://www.hindawi.com/GetArticle.aspx?doi=10.1155/2007/39245</link><description>Cellular retinaldehyde binding protein (CRALBP) is an autoantigen in spontaneous equine recurrent uveitis. In
order to test whether CRALBP contributes to human autoimmune uveitis, the specificity of antibodies from human
uveitis patient&amp;#39;s sera was first evaluated in two-dimensional (2D) Western blot analysis. Subsequent identification of the immunoreactive proteins by mass spectrometry resulted in the identification of CRALBP as a putative autoantigen. Additionally, sera from human uveitis and control patients  were  by Western blot  using purified human recombinant CRALBP. Anti-CRALBP autoantibodies occur more frequently (P&amp;#x003C;.01) in human uveitis patients than in normal controls. Thirty out of 56 tested uveitis patient&amp;#39;s sera contained autoantibodies reactive against CRALBP, compared to only four out of 23 normal control subjects. The presence of CRALBP autoantibodies in 54&amp;#37; of tested uveitis patients supports CRALBP as a possible autoantigen in human autoimmune uveitis.</description><Author>Cornelia A. Deeg, Albert J. Raith, Barbara Amann, John W. Crabb, Stephan R. Thurau, Stefanie M. Hauck, Marius Ueffing, Gerhild Wildner, and Manfred Stangassinger</Author><copyright>&amp;#169; 2008, Hindawi Publishing Corporation. All rights reserved.</copyright></item><item><title>IPEX as a Result of Mutations in FOXP3</title><link>http://www.hindawi.com/GetArticle.aspx?doi=10.1155/2007/89017</link><description>Immunodysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome is a rare disorder caused by mutations in the FOXP3 gene that result in the defective development of CD4+CD25+ regulatory T cells which constitute an important T cell subset involved in immune homeostasis and protection against autoimmunity. Their deficiency is the hallmark of IPEX and leads to severe autoimmune phenomena including autoimmune enteropathy, dermatitis, thyroiditis, and type 1 diabetes, frequently resulting in death within the first 2 years of life. Apart from its clinical implications, IPEX illustrates the importance of immunoregulatory cells such as CD4+CD25+ regulatory T cells.</description><Author>Hans J. J. van der Vliet and Edward E. Nieuwenhuis</Author><copyright>&amp;#169; 2008, Hindawi Publishing Corporation. All rights reserved.</copyright></item></channel></rss>